Sunshine Biopharma Company Leadership

Sunshine Biopharma Management Team Effectiveness

The company has return on total asset (ROA) of (0.1108) % which means that it has lost $0.1108 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2565) %, meaning that it created substantial loss on money invested by shareholders. Sunshine Biopharma's management efficiency ratios could be used to measure how well Sunshine Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of February 2026, Return On Tangible Assets is likely to drop to -0.18. In addition to that, Return On Capital Employed is likely to grow to -0.26. At this time, Sunshine Biopharma's Intangible Assets are very stable compared to the past year. As of the 16th of February 2026, Intangibles To Total Assets is likely to grow to 0.11, while Return On Tangible Assets are likely to drop (0.18). As of the 16th of February 2026, Common Stock Shares Outstanding is likely to grow to about 847.4 K, though Net Loss is likely to grow to (22.9 M). About 94.45 % of Sunshine Biopharma outstanding shares are held by general public with 2.94 (%) owned by insiders and only 2.61 % by institutional holders. Some institutional investors establish a significant position in stocks such as Sunshine Biopharma in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Sunshine Biopharma, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Sunshine Biopharma Workforce Comparison

The company has Profit Margin (PM) of (0.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.

Sunshine Biopharma Insider Trading

Sunshine Biopharma Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Sunshine Biopharma often depends on how effective the management is. Sunshine Biopharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sunshine management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sunshine management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Investors evaluate Sunshine Biopharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sunshine Biopharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sunshine Biopharma's market price to deviate significantly from intrinsic value.

Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sunshine Biopharma's market price signifies the transaction level at which participants voluntarily complete trades.